The OPTIMAL Study: a prospective cohort of patients with bone metastases of the long bones

The OPTIMAL Study: a prospective cohort of patients with bone metastases of the long bones - OPTIMAL study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47589

Enrollment

1800

Registered

2015-11-24

Start date

2016-01-20

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic bone disease skeletal metastasis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Aged 18 or older - Radiographic or histologic proof of metastatic bone disease - Histologic diagnosis of the primary tumour or * if the diagnosis is unknown - at least adequate diagnostic investigations into the origin of the metastasis (e.g. dissemination imaging, histology, biopsy) - Bone metastasis deriving from the bones of the extremities

Exclusion criteria

Exclusion criteria: - Primary bone tumours (benign and/or malignant) - No informed consent signed - Communication with patient is hampered (e.g. language barrier, severe cognitive impairment, dementia)

Design outcomes

Primary

Measure	Time frame
Primary endpoints are patient reported quality of life (including functioning) and pain levels.	—

Secondary

Measure	Time frame
Complications, revisions, and survival are secondary endpoints.	—

Countries

Netherlands

Outcome results